Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Item No. 25005

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.
OBESITY RESEARCH SOLUTIONSOxyntomodulin, also known as glucagon-37, is a 37-amino acid peptide produced in bovine and porcine gut.1,2 It reduces [125I]-glucagon binding to rat liver plasma membranes and a glucagon antibody in a concentration-dependent manner.1 Oxyntomodulin induces insulin secretion in a glucose- and concentration-dependent manner in perfused rat pancreas.3 It increases glucose absorption in isolated rat small intestine and enterocytes.4 In vivo, oxyntomodulin (25-450 pmol/kg) inhibits pentagastrin-stimulated gastric acid secretion in a dose-dependent manner in rats.5 It also increases plasma concentrations of insulin and glucose in Holstein cattle under normal physiological conditions.2
WARNING This product is not for human or veterinary use.
1. Isolation of glucagon-
2. Oxyntomodulin increases the concentrations of insulin and glucose in plasma but does not affect ghrelin secretion in Holstein cattle under normal physiological conditions. Domest. Anim. Endocrinol. 39(3), 163-170 (2010).
3. A pure enteroglucagon, oxyntomodulin (glucagon 37), stimulates insulin release in perfused rat pancreas. Endocrinology 115(1), 102-105 (1984).
4. A new role for enteric glucagon-
5. Oxyntomodulin (glucagon-